83
Publications
38K
Citations
58
H-Index
1984
Active since
Terrill K. McClanahan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and inflammation.
Top concepts
MedicineImmunologyCell BiologyInflammationAutoimmunityAutoimmune DiseaseImmunotherapyImmune RegulationT Cell ImmunityCell Signaling
Publications per year
1984–2022
83
83
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers, Jared Lunceford, Michael Nebozhyn et al. · Journal of Clinical Investigation · 2017 · 3.7K citations · Full text
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
Răzvan Cristescu, Robin Mogg, Mark Ayers et al. · Science · 2018 · 2.3K citations
Checkpoint Blockade Immunotherapy, Immunology, Immune Cell Therapy +16
Tanguy Y. Seiwert, Barbara Burtness, Ranee Mehra et al. · The Lancet Oncology · 2016 · 1.7K citations
Rows per page
1–5 of 83